XML 28 R17.htm IDEA: XBRL DOCUMENT
v3.25.2

WARRANT LIABILITY | 3 Months Ended
--- | ---
Jul. 31, 2025
Warrant Liability |
WARRANT LIABILITY | NOTE 9 — WARRANT LIABILITY As of July 31, 2025 and April 30, 2025, the Company’s warrant liabilities were valued at $0 and $11,631,100, respectively. Under the guidance in ASC 815-40, certain warrants did not meet the criteria for equity treatment. These warrants included a clause whereby the warrant holder may be entitled to receive a net cash settlement upon the completion of a “fundamental transaction.” A fundamental transaction, as defined in the warrants, includes (a) any merger or consolidation by and between the Company and another Person, (b) the sale or other disposition by the Company of all or substantially all of its assets, (c) the completion of any tender offer or exchange offer pursuant to which the holders of greater than 50% of the Company’s outstanding common stock has agreed to tender or exchange their securities, and (d) the consummation of a stock purchase agreement or other business combination whereby another Person acquires more than 50% of the outstanding shares of common stock of the Company. In the event of a fundamental transaction, the holder of the warrant has the right to require that the Company purchase the warrant from the holder by paying the holder an amount of cash equal to a valuation based on the Black-Scholes Option Pricing Model reflecting an expected volatility equal to the greater of 100% or the 100-day volatility as of the trading day immediately following the public announcement of the applicable fundamental transaction. This volatility input precludes the Company from applying equity accounting as the warrant holder could receive a net cash settlement value that is greater than a holder of the Company’s common stock. Accordingly, the Company concluded that liability accounting was required. The Company utilized a Monte Carlo Simulation model to estimate the fair values of the April 2023 and March 2022 warrants, which incorporated significant inputs that were not observable in the market, and thus represents a Level 3 measurement as defined in ASC 820. The unobservable inputs utilized for measuring the fair value of the contingent consideration reflect management’s own assumptions about the assumptions that market participants would use in valuing the contingent consideration. The Company determined the fair value by using the below key inputs to the Monte Carlo Simulation Model. As such, these warrants are recorded at fair value as of each reporting date with the change in fair value reported within other income in the accompanying consolidated statements of operations as “Change in fair value of warrant liability” until the warrants are exercised, expired or other facts and circumstances lead the warrant liability to be reclassified to stockholders’ equity. In May 2025, the Company issued an aggregate of 870,000 shares of common stock upon the exercise of the 870,000 common stock purchase warrants and received proceeds of approximately $5,359,200. Additionally, in May 2025, the Company issued an aggregate of 260,071 shares of common stock upon the cashless exercise of the 625,000 common stock purchase warrants. Therefore, the fair value of the warrant liability on the date of exercise of $10,136,100 was reclassified into additional paid-in capital in May 2025. Measurement The Company accounted for the 625,000 warrants issued on March 18, 2022 and the 870,000 warrants issued on April 10, 2023, in accordance with the guidance contained in ASC 815 “Derivatives and Hedging” whereby under that provision these warrants did not meet the criteria for equity treatment and were recorded as a liability. In May 2025, the fair value of the warrant liability on the date of exercise was reclassified into additional paid-in capital (see above). The key inputs for the warrant liability were as follows as of May 2, 2025 (the valuation date before the date of exercise): SCHEDULE OF KEY INPUTS FOR THE WARRANT LIABILITY
Key Valuation Inputs |  |  |
Expected term (years) |  |  | 3.44 |
Annualized volatility |  |  | 64.2 | %
Volatility if fundamental transaction occurs |  |  | 100.00 | %
Risk-free interest rate |  |  | 3.84 | %
Stock price |  | $ | 9.99 |
Dividend yield |  |  | 0.00 | %
Exercise price |  | $ | 6.16 |
Probability of fundamental transaction |  |  | 95 | %
Date of fundamental transaction |  |  | 0.25 years to 3.44 years |
U.S. GOLD CORP. AND SUBSIDIARIES NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS JULY 31, 2025 The key inputs for the warrant liability were as follows as of April 30, 2025:
Key Valuation Inputs |  |  |
Expected term (years) |  |  | 3.45 |
Annualized volatility |  |  | 64.0 | %
Volatility if fundamental transaction occurs |  |  | 100.00 | %
Risk-free interest rate |  |  | 3.61 | %
Stock price |  | $ | 10.97 |
Dividend yield |  |  | 0.00 | %
Exercise price |  | $ | 6.16 |
Probability of fundamental transaction |  |  | 95 | %
Date of fundamental transaction |  |  | 0.25 years to 3.45 years |
The following table sets forth a summary of the changes in the fair value of the Level 3 warrant liability for the three months ended July 31, 2025: SCHEDULE OF CHANGES IN FAIR VALUE OF LEVEL 3 WARRANT LIABILITY
|  | Warrant Liability |
Fair value as of April 30, 2025 |  | $ | 11,631,100 |
Change in fair value |  |  | (1,495,000 | )
Reclassification into equity upon warrant exercise |  |  | (10,136,100 | )
Fair value as of July 31, 2025 |  | $ | - |

X
- References No definition available. + Details
Name: | USAU_DisclosureWarrantLiabilityAbstract
Namespace Prefix: | USAU_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Warrant Liability [Text Block] + References No definition available. + Details
Name: | USAU_WarrantLiabilityTextBlock
Namespace Prefix: | USAU_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration